Life Scientist > Biotechnology

LabTech awarded patent for key technology

18 August, 2009 by Tim Dean

Australian patent awarded for LabTech System's MicroStreak agar plate streaking technology.


CSIRO opens high tech green biolab

17 August, 2009 by Tim Dean

New environmentally-friendly biotechnology facility opened in Canberra.


Australian biotech market watch 13/08/09

13 August, 2009 by Tim Dean

BioPharmica, Ansell, Sonic, iSOFT, Progen, pSivida


UQ licenses hGH to PROLOR

12 August, 2009 by Staff Writers

IMBcom and PROLOR Biotech enter into technology licence for human growth hormone.


Prognosis good for Primary Health Care

12 August, 2009 by Tim Dean

Profits up more than tenfold following acquisition of Symbion in 2008.


BioProspect acquisition of Re-Gen complete

10 August, 2009 by Staff Writers

Plans to expand into rapidly growing Chinese market for natural health products.


Australian biotech market watch 07/08/09

07 August, 2009 by Tim Dean

ResMed, Ramsay, Biota, Sonic, Healthscope


Mesoblast targets heart failure in trial

05 August, 2009 by Tim Dean

Adult stem cells might eliminate the need for heart transplants in heart failure patients.


FDA-approved manufacturing plant opens in Sydney

05 August, 2009 by Tim Dean

Facility for manufacture of highly potent sterile injectables opened by Parnell.


Starpharma announces positive trial results

04 August, 2009 by Tim Dean

VivaGel demonstrates anti-HIV and herpes simplex virus properties.


Australian biotech market watch 31/07/09

31 July, 2009 by Tim Dean

HeartWare, Universal Biosensors, Fisher & Paykel, CSL


Trial of electrical stimulation treatment for depression

28 July, 2009 by Staff Writers

Participants sought for trial using electrical brain stimulation to treat depression.


New method produces better biological factories

27 July, 2009 by Staff Writers

Parallel gene manipulation speeds up creation of lycopene-producing bacteria.


Australian biotech market watch 24/07/09

24 July, 2009 by Tim Dean

Ansell, CathRX, CSL, Primary Health Care, Sirtex, Living Cell Technologies, Biota, Cochlear


New drug may reduce heart attack damage

23 July, 2009 by Staff Writers

One-off drug delivery could dramatically improve treatment of Australia’s number one killer.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd